Decreased PEMT Gene Expression In The Liver Is Linked To Severity In Nonalcoholic Fatty Liver Disease

PHOENIX, Ariz. — August 22, 2022 — Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an essential nutrient for humans— and severity of NAFLD.

Continue reading

White Hat Life Science Investor Conference Connects Innovators and Investors

The White Hat Life Science Investor Conference, a biotech and healthcare investor conference, will showcase exciting biotech and medtech companies from across the Rocky Mountain & Southwest Region September 28-29, 2022 during Arizona Bioscience Week.

Investors will have the opportunity to connect with a new generation of biotech and healthcare pioneers in person and to schedule meetings via the Arizona Bioscience Week app.Continue reading